Skip to content

Impact of SPN on Infection Rate, Duration of Mechanical Ventilation & Rehabilitation in ICU Patients

Impact of Supplemental Parenteral Nutrition (SPN) on Infection Rate, Duration of Mechanical Ventilation and Rehabilitation in Intensive Care Unit Patients: A Quality Control Program for the Implementing of New Nutrition Guidelines

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00802503
Enrollment
305
Registered
2008-12-05
Start date
2008-05-31
Completion date
2011-07-31
Last updated
2013-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically Ill

Keywords

Critically ill, nutrition, randomised controlled clinical trial, human, adult, Supplemental parenteral nutrition

Brief summary

Rationale: Enteral nutrition (EN) in the intensive care (ICU) patients is recommended as a standard of care. However, EN alone is often associated with insufficient energy intakes and increased complication rates. Recently the investigators proposed to decrease this deficit by combining EN and supplemental parenteral nutrition (SPN) whenever EN is insufficient (\< 60% of their predicted energy needs) at day 3 after admission in the ICU. Objective: This study aims at: a/ investigating if the delivery of optimal nutrition support (100 % of predicted energy targets) in ICU patients by the combined administration of SPN and EN optimizes their clinical outcome; b/ implementing the new ICU nutrition guidelines. Study design: Prospective, controlled, randomized clinical study. Study site: Service of Intensive Care, Geneva University Hospital. Patient population: 220 ICU patients to be included: expected length of stay \> 5 days, expected survival \> 7 days, no contraindication to EN, obtained informed consent from themselves or their next of keen. Exclusion criteria: refusal of consent, age \< 18 years, short bowel syndrome, significant persistent gastrointestinal dysfunction with ileus, high output proximal fistula (\> 1,5 liter/d), patients receiving PN. Nutrition: At day 3 after admission, if energy input is \< 60%; patients are randomized into either the Control group (EN alone) or the SPN group (EN + PN) to reach 100% of their predicted energy needs. Tight glycaemic control (target 6.0 to 8.3 mmol/l) to be achieved according to our local practice by insulin administration. Study endpoints: * Primary: nosocomial infections (CDC criteria) * Secondary: Mechanical ventilation duration, ICU and hospital length of stay, antibiotic free days, ICU complications (extra-renal epuration, neurological, cardiac and respiratory complications), energy and protein balance, 28 days clinical outcome.

Detailed description

Introduction: Nutritional support of the intensive care (ICU) patients is recommended as a standard of care. It is also strongly recommended to start enteral feeding as soon as possible whenever the gastrointestinal tract is functioning (1). However, studies have repeatedly shown that with enteral support alone, insufficient energy and protein intakes often occur (2). The resulting energy and protein deficit is associated with an increased complication rate in ICU patients (3-5). Recently we proposed to decrease this deficit by promoting a combined nutrition support by enteral nutrition (EN) and supplemental parenteral nutrition (SPN) whenever EN is insufficient (6). Contrary to former beliefs, recent meta-analyses show that parenteral nutrition (PN) does not carry excess mortality (7, 8). These reports convey a concept that is a major break-through in current routine of nutritional support in ICU patients by promoting a much wider use of PN. SPN could be the optimal modality to provide the calculated energy targets if this cannot be reached by EN alone. To improve ICU patient's outcome and minimise complications, we propose to implement feeding protocols which combine both EN and PN, when EN is insufficient to cover more than 60% of caloric needs at day 4 to reach 100% of the energy targets by adding PN from day 4 (6). Hypothesis: The administration of SPN, in ICU patients receiving \< 60% of targeted energy needs by EN alone, has a positive impact on their clinical outcome by optimising their nutritional support (reduced infectious complications rate, mechanical ventilation days, duration of ICU and hospital length of stay and rehabilitation). Objective: The aim of the present study is to investigate if the delivery of optimal nutrition support (100 % of predicted energy targets) in ICU patients achieved with the combined administration of SPN and EN optimizes their clinical outcome.

Interventions

DIETARY_SUPPLEMENTSPN

SPN : in the treated group, SPN is started if at day 4 energy input by EN is \< 60% of energy target in order to reach 100% of energy target by peripheral or central line.

Sponsors

University of Lausanne Hospitals
CollaboratorOTHER
University Hospital, Geneva
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Expected ICU stay \> 5 days * Expected survival \> 7 days * No contraindication to EN * Obtained informed consent

Exclusion criteria

* Refusal of consent * Age \< 18 years * Short bowel syndrome * Significant persistent gastrointestinal dysfunction with ileus * High output proximal fistula (\> 1.5 liter/d) * Patients receiving PN

Design outcomes

Primary

MeasureTime frameDescription
Documented Infection Rate20 daysInfection, defined according to CDC criteria during the ICU and hospital stay, occurrence between day 9 and day 28

Secondary

MeasureTime frameDescription
Antibiotic Free Days20 daysNumber of days between day 9 to day 28 (follow-up period) free of antibiotics
Total Energy Intake During the Intervention Period , Between Day 4 and Day 8.5 daysPercentage of energy target; in the SPN group the goal was to achieve 100% of the energy target during intervention (day 4 to day 8.The energy target was measured by indirect calorimetry in 198 patients of 305(65%),otherwise energy target was calculated by 25 kcal per kg of ideal body weight for women and 30 kcal per kg of ideal body weight for men and anamnestic body weight was used for patients with a body mass index of 20 kg/m2 or lower.
General Mortality28 days
Hours on Mechanical Ventilation in All Patients28 daysMechanical ventilation hours during study duration (days 1-28)
ICU Mortality28 days
Protein Delivery During the Intervention Period From Day 4 to Day 85 daysPercentage of protein target between day 4 to 8. Protein target was set to 1.2 g per kg of ideal body weight a day.
Days in Hospital28 dayshospital length of stay
Days in ICU28 daysDays in ICU

Countries

Switzerland

Participant flow

Participants by arm

ArmCount
Control gr
EN : start EN at 20-30 ml/h per day up to maximal 150 ml/h per day; or day1: 500 ml, day2: 1000 ml, day3: 1500 ml of EN dependant on gastrointestinal tolerance (gastric residue volume more than 500ml). Nutritional products as currently used in our institution.
152
SPN Group
experimental arm: Supplemental Parenteral Nutrition (SPN) is added to enteral nutrition (EN) to reach 100% of their predicted energy needs from ICU day 4. In the treated group, SPN is started if at day 4 energy input by EN is \< 60% of energy target in order to reach 100% of energy target by peripheral or central line. Nutritional products as currently used in our institution. SPN is composed of EN and PN, both techniques being currently used in our institution. SPN : SPN : in the treated group, SPN is started if at day 4 energy input by EN is \< 60% of energy target in order to reach 100% of energy target by peripheral or central line.
153
Total305

Baseline characteristics

CharacteristicSPN GroupControl grTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
70 Participants61 Participants131 Participants
Age, Categorical
Between 18 and 65 years
83 Participants91 Participants174 Participants
Age Continuous61 years
STANDARD_DEVIATION 16
60 years
STANDARD_DEVIATION 16
60 years
STANDARD_DEVIATION 17
Region of Enrollment
Switzerland
153 participants152 participants305 participants
Sex: Female, Male
Female
43 Participants47 Participants90 Participants
Sex: Female, Male
Male
110 Participants105 Participants215 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1520 / 153
serious
Total, serious adverse events
0 / 1520 / 153

Outcome results

Primary

Documented Infection Rate

Infection, defined according to CDC criteria during the ICU and hospital stay, occurrence between day 9 and day 28

Time frame: 20 days

ArmMeasureValue (NUMBER)
Control grDocumented Infection Rate58 Infections
SPN GroupDocumented Infection Rate41 Infections
Secondary

Antibiotic Free Days

Number of days between day 9 to day 28 (follow-up period) free of antibiotics

Time frame: 20 days

Population: The intention to treat analysis included all patients randomly assigned to the intervention SPN group (153) or control group EN (152). The per protocol analysis included only patients who fully completed the 5-day intervention in the ICU (SPN group(133); EN group (142).

ArmMeasureValue (MEAN)
Control grAntibiotic Free Days12 number of days
SPN GroupAntibiotic Free Days14 number of days
Secondary

Days in Hospital

hospital length of stay

Time frame: 28 days

Population: The intention to treat analysis included all patients randomly assigned to the intervention SPN group (153) or control group EN (152). The per protocol analysis included only patients who fully completed the 5-day intervention in the ICU (SPN group(133); EN group (142).

ArmMeasureValue (MEAN)
Control grDays in Hospital32 days in hospital
SPN GroupDays in Hospital31 days in hospital
Secondary

Days in ICU

Days in ICU

Time frame: 28 days

Population: The intention to treat analysis included all patients randomly assigned to the intervention SPN group (153) or control group EN (152). The per protocol analysis included only patients who fully completed the 5-day intervention in the ICU (SPN group(133); EN group (142).

ArmMeasureValue (MEAN)
Control grDays in ICU13 days in ICU
SPN GroupDays in ICU13 days in ICU
Secondary

General Mortality

Time frame: 28 days

Population: The intention to treat analysis included all patients randomly assigned to the intervention SPN group (153) or control group EN (152). The per protocol analysis included only patients who fully completed the 5-day intervention in the ICU (SPN group(133); EN group (142).

ArmMeasureValue (NUMBER)Dispersion
Control grGeneral Mortality28 participants 18
SPN GroupGeneral Mortality20 participants 13
Secondary

Hours on Mechanical Ventilation in All Patients

Mechanical ventilation hours during study duration (days 1-28)

Time frame: 28 days

Population: The intention to treat analysis included all patients randomly assigned to the intervention SPN group (153) or control group EN (152). The per protocol analysis included only patients who fully completed the 5-day intervention in the ICU (SPN group(133); EN group (142).

ArmMeasureValue (MEAN)
Control grHours on Mechanical Ventilation in All Patients166 hours of mechanical ventilation
SPN GroupHours on Mechanical Ventilation in All Patients153 hours of mechanical ventilation
Secondary

ICU Mortality

Time frame: 28 days

Population: The intention to treat analysis included all patients randomly assigned to the intervention SPN group (153) or control group EN (152). The per protocol analysis included only patients who fully completed the 5-day intervention in the ICU (SPN group(133); EN group (142).

ArmMeasureValue (NUMBER)
Control grICU Mortality12 participants
SPN GroupICU Mortality8 participants
Secondary

Protein Delivery During the Intervention Period From Day 4 to Day 8

Percentage of protein target between day 4 to 8. Protein target was set to 1.2 g per kg of ideal body weight a day.

Time frame: 5 days

Population: The intention to treat analysis included all patients randomly assigned to the intervention SPN group (153) or control group EN (152). The per protocol analysis included only patients who fully completed the 5-day intervention in the ICU (SPN group(133); EN group (142).

ArmMeasureValue (MEAN)Dispersion
Control grProtein Delivery During the Intervention Period From Day 4 to Day 871 percentage of protein targetStandard Deviation 27
SPN GroupProtein Delivery During the Intervention Period From Day 4 to Day 8100 percentage of protein targetStandard Deviation 16
Secondary

Total Energy Intake During the Intervention Period , Between Day 4 and Day 8.

Percentage of energy target; in the SPN group the goal was to achieve 100% of the energy target during intervention (day 4 to day 8.The energy target was measured by indirect calorimetry in 198 patients of 305(65%),otherwise energy target was calculated by 25 kcal per kg of ideal body weight for women and 30 kcal per kg of ideal body weight for men and anamnestic body weight was used for patients with a body mass index of 20 kg/m2 or lower.

Time frame: 5 days

Population: The intention to treat analysis included all patients randomly assigned to the intervention SPN group (153) or control group EN (152). The per protocol analysis included only patients who fully completed the 5-day intervention in the ICU (SPN group(133); EN group (142).

ArmMeasureValue (MEAN)Dispersion
Control grTotal Energy Intake During the Intervention Period , Between Day 4 and Day 8.77 % of energy targetStandard Deviation 27
SPN GroupTotal Energy Intake During the Intervention Period , Between Day 4 and Day 8.103 % of energy targetStandard Deviation 18

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026